All Stories

  1. ‘If we would change things outside we wouldn’t even need to go in…’ supporting recovery via community‐based actions: A focus group study on psychiatric rehospitalization
  2. Action by non-governmental organisations on the social determinants of mental health
  3. Using national electronic health care registries for comparing the risk of psychiatric re-hospitalisation in six European countries: Opportunities and limitations
  4. Identifying Local and Centralized Mental Health Services—The Development of a New Categorizing Variable
  5. A Comparison of Mental Health Care Systems in Northern and Southern Europe: A Service Mapping Study
  6. Exploiting routine data for international benchmarking of quality in mental health care
  7. Promoting mental wellbeing among older people: technology-based interventions
  8. Mortality and causes of death among homeless in Finland: a 10-year follow-up study
  9. Overview of post-discharge predictors for psychiatric re-hospitalisations: a systematic review of the literature
  10. Mental disorders and the use of primary health care services among homeless shelter users in the Helsinki metropolitan area, Finland
  11. National funding for mental health research in Finland, France, Spain and the United Kingdom
  12. Interventions to mitigate the effects of poverty and inequality on mental health
  13. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas
  14. Psychiatric readmissions and their association with physical comorbidity: a systematic literature review
  15. Regional Correlates of Psychiatric Inpatient Treatment
  16. Pre-discharge factors predicting readmissions of psychiatric patients: a systematic review of the literature
  17. Statistical methods and modelling techniques for analysing hospital readmission of discharged psychiatric patients: a systematic literature review
  18. Psychiatric readmissions and their association with environmental and health system characteristics: a systematic review of the literature
  19. How size matters: exploring the association between quality of mental health services and catchment area size
  20. Antidepressant use and violent crimes among young people: a longitudinal examination of the Finnish 1987 birth cohort
  21. Discrimination in the workplace, reported by people with major depressive disorder: a cross-sectional study in 35 countries
  22. The Impact of the 2008 Economic Crisis on Substance Use Patterns in the Countries of the European Union
  23. Developing a tool for mapping adult mental health care provision in Europe: the REMAST research protocol and its contribution to better integrated care
  24. Cross-national variations in reported discrimination among people treated for major depression worldwide: The ASPEN/INDIGO international study
  25. Mental health research priorities for Europe
  26. Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: A nationwide registry-based prospective cohort study
  27. Contribution of the Nordic School of Public Health to the public mental health research field: a selection of research initiatives, 2007–2014
  28. Research priorities for public mental health in Europe: recommendations of the ROAMER project
  29. Public mental health and suicide
  30. Public mental health: the time is ripe for translation of evidence into practice
  31. Self-stigma as a mediator between social capital and empowerment among people with major depressive disorder in Europe: The ASPEN study
  32. Maternal Grand Multiparity and the Risk of Severe Mental Disorders in Adult Offspring
  33. Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden
  34. Late preterm birth, post-term birth, and abnormal fetal growth as risk factors for severe mental disorders from early to late adulthood
  35. Mental health and alcohol use: a cross-sectional study of the Finnish general population
  36. Does Primary Care Mental Health Resourcing Affect the Use and Costs of Secondary Psychiatric Services?
  37. Size Matters — Determinants of Modern, Community-Oriented Mental Health Services
  38. The state of the art in European research on reducing social exclusion and stigma related to mental health: A systematic mapping of the literature
  39. Towards Horizon 2020: challenges and advances for clinical mental health research – outcome of an expert survey
  40. Public mental health research in Europe: a systematic mapping for the ROAMER project
  41. Twenty-eight years after the complete ban on the physical punishment of children in Finland: Trends and psychosocial concomitants
  42. Social capital and reported discrimination among people with depression in 15 European countries
  43. Enhancing Mental Health and Mental Wellbeing in Older People
  44. Promoting and Protecting Mental Wellbeing during Times of Economic Change
  45. Promoting the Health and Wellbeing of Older People
  46. Prenatal and Childhood Growth, and Hospitalization for Alcohol Use Disorders in Adulthood: The Helsinki Birth Cohort Study
  47. EPA-1404 – Mental health in all policies
  48. ROAMER: roadmap for mental health research in Europe
  49. Associations between problem gambling, socio-demographics, mental health factors and gambling type: sex differences among Finnish gamblers
  50. Patterns in mortality among people with severe mental disorders across birth cohorts: a register-based study of Denmark and Finland in 1982–2006
  51. Life Expectancy and Death by Diseases of the Circulatory System in Patients with Bipolar Disorder or Schizophrenia in the Nordic Countries
  52. Structural and Cognitive Aspects of Social Capital and All-Cause Mortality: A Meta-Analysis of Cohort Studies
  53. Excess Mortality, Causes of Death and Life Expectancy in 270,770 Patients with Recent Onset of Mental Disorders in Denmark, Finland and Sweden
  54. Nature and impact of European anti-stigma depression programmes
  55. Substance-Induced Psychoses Converting Into Schizophrenia
  56. Suicide mortality trends in the Nordic countries 1980–2009
  57. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden
  58. Global pattern of experienced and anticipated discrimination reported by people with major depressive disorder: a cross-sectional survey
  59. Socioeconomic and regional aspects in the use of specialized psychiatric care—a Finnish nationwide follow-up study
  60. Development of the ITHACA Toolkit for monitoring human rights and general health care in psychiatric and social care institutions
  61. Actions to alleviate the mental health impact of the economic crisis
  62. Temporary Separation from Parents in Early Childhood and Serious Personality Disorders in Adult Life
  63. Structural and cognitive social capital and depression among older adults in two Nordic regions
  64. Experiences with treating immigrants: a qualitative study in mental health services across 16 European countries
  65. Understanding the role of social capital for mental wellbeing among older adults
  66. Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: The Helsinki Birth Cohort Study
  67. How does a history of psychiatric hospital care influence access to coronary care: a cohort study
  68. Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders
  69. Psychosocial interventions for the promotion of mental health and the prevention of depression among older adults
  70. Supporting decision-making processes for evidence-based mental health promotion
  71. Reported Stigma and Discrimination by People with a Diagnosis of Schizophrenia – CORRIGENDUM
  72. Growth in Infancy and Childhood and Hospitalization for Personality Disorders in Adulthood: The Helsinki Birth Cohort Study
  73. Cognitive components of social capital and mental health status among older adults: A population-based cross-sectional study
  74. European mental health policy should target everybody
  75. Glucocorticoid receptor gene haplotype predicts increased risk of hospital admission for depressive disorders in the Helsinki birth cohort study
  76. Reducing the Silent Burden of Impaired Mental Health
  77. O27. Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: The Helsinki Birth Cohort study
  78. P42. Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: The Helsinki Birth Cohort Study
  79. Successful deinstitutionalization of mental health care: increased life expectancy among people with mental disorders in Finland
  80. ASPEN: Anti Stigma Programme European Network
  81. Monitoring human rights in mental health: the ITHACA toolkit
  82. What do we know about economic evaluations of psychosocial interventions to promote mental health and wellness in older people?
  83. Personal stigma and use of mental health services among people with depression in a general population in Finland
  84. Good practice in health care for migrants: views and experiences of care professionals in 16 European countries
  85. Reported stigma and discrimination by people with a diagnosis of schizophrenia
  86. European comparisons between mental health services
  87. Risk of severe mental disorders in adults separated temporarily from their parents in childhood: The Helsinki birth cohort study
  88. Psychosocial Interventions for the Prevention of Depression in Older Adults: Systematic Review and Meta-Analysis
  89. Increase in the duration of antidepressant treatment from 1994 to 2003: a nationwide population-based study from Finland
  90. Prenatal origins of hospitalization for personality disorders: The Helsinki Birth Cohort Study
  91. Predictors of stigmatizing attitudes towards people with mental disorders in a general population in Finland
  92. Beta-Blocker Supplementation of Standard Drug Treatment for Schizophrenia
  93. Use of psychotropic drugs before pregnancy and the risk for induced abortion: population-based register-data from Finland 1996-2006
  94. Incidence of hospitalised schizophrenia in Finland since 1980: decreasing and increasing again
  95. Cost-utility of treatment of bulimia nervosa
  96. Incidence of cancer and antidepressant medication: Record linkage study
  97. Incidence of cancer and statin usage—Record linkage study
  98. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
  99. Attitudes towards people with mental disorders: the psychometric characteristics of a Finnish questionnaire
  100. Psychosocial interventions for prevention of depression in older people
  101. The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis
  102. Community mental-health services and suicide rate in Finland: a nationwide small-area analysis
  103. Five-year mortality of Finnish schizophrenia patients in the era of deinstitutionalization
  104. Associations between childhood living circumstances and schizophrenia:
a population-based cohort study
  105. Neuroleptic-induced movement disorders in a naturalistic schizophrenia population: diagnostic value of actometric movement patterns
  106. Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: A double-blind randomised placebo controlled 6-month trial
  107. Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls
  108. Real-world effectiveness of pharmacological treatments in schizophrenia
  109. Reductions in Postdischarge Suicide After Deinstitutionalization and Decentralization: A Nationwide Register Study in Finland
  110. Organisational downsizing and increased use of psychotropic drugs among employees who remain in employment
  111. Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort
  112. Europe's mental health strategy
  113. Glutamatergic drugs for schizophrenia
  114. Call for a European Guidelines Institute
  115. P.2.c.016 Antidepressant use and the risk of suicide, attempted suicide and overall mortality in a nation-wide cohort
  116. European psychiatric treatment guidelines: is the glass half full or half empty?
  117. Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials
  118. Restraint and seclusion in psychiatric inpatient wards
  119. The characteristics of suicides within a week of discharge after psychiatric hospitalisation – a nationwide register study
  120. Actometry in measuring the symptom severity of restless legs syndrome
  121. Mental disorders in prison populations aged 15-21: national register study of two cohorts in Finland
  122. Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population
  123. Comparison of Large Versus Smaller Randomized Trials for Mental Health-Related Interventions
  124. Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis
  125. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia
  126. Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials
  127. Safety Reporting in Randomized Trials of Mental Health Interventions
  128. Lower limb motor restlessness in Asperger's disorder, measured using actometry
  129. Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial
  130. No association between micrometer-sized particles in human cerebrospinal fluid and schizophrenia
  131. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis
  132. Quantitative rest activity in ambulatory monitoring as a physiological marker of restless legs syndrome: A controlled study
  133. A meta-analysis comparing “atypical” antipsychotis with low-potency conventional antipsychotics. Is less more?
  134. Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials
  135. Differential response to right unilateral ECT in depressed patients: impact of comorbidity and severity of illness [ISRCTN39974945]
  136. Dropout rates in randomised antipsychotic drug trials
  137. Association of Schizophrenia With Low Maternal Body Mass Index, Small Size at Birth, and Thinness During Childhood
  138. Risperidone versus clozapine in treatment-resistant schizophrenia: A randomized pilot study
  139. Influence of Methodology on Outcomes of Randomised Clozapine Trials
  140. Current antipsychotic dose correlates to mononuclear cell counts in the cerebrospinal fluid of psychotic patients
  141. Are UK consultants interested in pragmatic trials for those with schizophrenia?
  142. Cerebrospinal fluid angiotensin-converting enzyme (ACE) correlates with length of illness in schizophrenia
  143. Low maternal body mass index, small size at birth and thinness during childhood are associated with schizophrenia: A population based cohort study
  144. Much to improve: A survey of controlled Nordic schizophrenia trials
  145. Risperidone versus clozapine in treatment-resistant schizophrenia: A randomized pilot trial
  146. CSF ace correlates with duration of illness in schizophrenia
  147. Is clozapine more effective than conventional neuroleptics in schizophrenia?—A systematic cochrane review
  148. Neuropeptide FF-Like Immunoreactivity in Human Cerebrospinal Fluid of Chronic Pain Patients and Healthy Controls
  149. The effect of clozapine on the course of illness in chronic schizophrenia
  150. Elevated plasma vasopressin and normal cerebrospinal fluid angiotensin-converting enzyme in chronic pain disorder
  151. Plasma and Cerebrospinal Fluid lnterleukin-1 β and lnterleukin-6 in Hospitalized Schizophrenic Patients
  152. Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of neuroleptic-treated schizophrenic patients
  153. Elevated angiotensin-converting enzyme (kininase II) in the cerebrospinal fluid of schizophrenic patients